Evidence map›Paper›PMID 24688895›Full record

ArticleRedox biology2014

High throughput assay for evaluation of reactive carbonyl scavenging capacity.

N Vidal, J P Cavaille, F Graziani, M Robin, O Ouari, S Pietri, P Stocker

Open access · goldAbstract read
In one paragraph

Article in Redox biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

N VidalAix Marseille Université, CNRS, ICR UMR 7273, 13397, Marseille, France.
J P CavailleAix Marseille Université, CNRS, ICR UMR 7273, 13397, Marseille, France.
F GrazianiAix Marseille Université, CNRS, ISM2 UMR 7313, 13397, Marseille, France.
M RobinAix Marseille Université, CNRS, ICR UMR 7273, 13397, Marseille, France.
O OuariAix Marseille Université, CNRS, ICR UMR 7273, 13397, Marseille, France.
S PietriAix Marseille Université, CNRS, ICR UMR 7273, 13397, Marseille, France.
P StockerAix Marseille Université, CNRS, ICR UMR 7273, 13397, Marseille, France.
Aix-Marseille Université · FRCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many carbonyl species from either lipid peroxidation or glycoxidation are extremely reactive and can disrupt the function of proteins and enzymes. 4-hydroxynonenal and methylglyoxal are the most abundant and toxic lipid-derived reactive carbonyl species. The presence of these toxics leads to carbonyl stress and cause a significant amount of macromolecular damages in several diseases. Much evidence indicates trapping of reactive carbonyl intermediates may be a useful strategy for inhibiting or decreasing carbonyl stress-associated pathologies. There is no rapid and convenient analytical method available for the assessment of direct carbonyl scavenging capacity, and a very limited number of carbonyl scavengers have been identified to date, their therapeutic potential being highlighted only recently. In this context, we have developed a new and rapid sensitive fluorimetric method for the assessment of reactive carbonyl scavengers without involvement glycoxidation systems. Efficacy of various thiol- and non-thiol-carbonyl scavenger pharmacophores was tested both using this screening assay adapted to 96-well microplates and in cultured cells. The scavenging effects on the formation of Advanced Glycation End-product of Bovine Serum Albumin formed with methylglyoxal, 4-hydroxynonenal and glucose-glycated as molecular models were also examined. Low molecular mass thiols with an α-amino-β-mercaptoethane structure showed the highest degree of inhibitory activity toward both α,β-unsaturated aldehydes and dicarbonyls. Cysteine and cysteamine have the best scavenging ability toward methylglyoxal. WR-1065 which is currently approved for clinical use as a protective agent against radiation and renal toxicity was identified as the best inhibitor of 4-hydroxynonenal.

Indexed as

AldehydesAnimalsCaco-2 CellsCell Line, TumorCysteamineCysteineGlycation End Products, AdvancedHigh-Throughput Screening AssaysHumansMercaptoethylaminesMicePyruvaldehydeSensitivity and SpecificitySerum Albumin, Bovine4-hydroxy-2-nonenalAldehydesCysteamineCysteineGlycation End Products, AdvancedMercaptoethylaminesN-(2-mercaptoethyl)-1,3-diaminopropanePyruvaldehydeSerum Albumin, BovineCarbonyl scavengerFluorescent adductReactive carbonyl speciesScreening assay

Identifiers

PMID24688895
PMCPMC3969608
OpenAlexW1997433810

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.